IBRX logo

Immunitybio Inc (IBRX)

ImmunityBio, Inc., a biotechnology company, focuses on innovating, developing, and commercializing next-generation immunotherapies designed to activate the patient's immune system and deliver durable protection against cancer and infectious diseases. Its platforms for the development of biologic products and product candidates that include cytokine fusion pr...

NASDAQHealthcareBiotechnologyUSA

公司简介

股票代码
IBRX
ISIN代码
US45256X1037
货币
US Dollar (USD)
IPO日期
2015-07-28

联系信息

公司地址
3530 John Hopkins Court, San Diego, CA, United States, 92121
联系电话
844 696 5235
公司网站
https://immunitybio.com
财年结束
December

财务亮点

市值
$999,999.99
毛利润(TTM)
$999,999.99
资产回报率(TTM)
-30.54%
EBITDA
$-999,999.99
收入(TTM)
$999,999.99